Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00087867. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma
ClinicalTrials.gov study NCT05353907. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access for TNB-383B in a Subject With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04453397. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib
ClinicalTrials.gov study NCT01060202. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT07191379. IPD Sharing: NO. Countries: 0. Publications: 0.
An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02568943. IPD Sharing: Not stated. Countries: 6. Publications: 0.
IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07185490. IPD Sharing: NO. Countries: 0. Publications: 0.
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00112879. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
ClinicalTrials.gov study NCT00899080. IPD Sharing: Not stated. Countries: 0. Publications: 0.
An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment Wit
ClinicalTrials.gov study NCT00216697. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Real-World Use of Selinexor, Daratumumab and Dexamethasone in Chinese Patients With Multiple Myeloma at First Relapse
ClinicalTrials.gov study NCT05559788. IPD Sharing: Not stated. Countries: 0. Publications: 0.
5p15/ 9q22/ 15q22 Hyperdiploidy and Their Significance in Multiple Myeloma Patients
ClinicalTrials.gov study NCT06667583. IPD Sharing: NO. Countries: 0. Publications: 0.
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
ClinicalTrials.gov study NCT00847366. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b
ClinicalTrials.gov study NCT00423644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype
GEO Series GSE33020. Homo sapiens. 6 samples. Type: Expression profiling by array.
MFF marks a metabolic vulnerability of multiple myeloma
GEO Series GSE286009. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
Expression data of the human multiple myeloma cell line MM1.S after AKT inhibition in a FOXO3 deficient background
GEO Series GSE120939. Homo sapiens. 8 samples. Type: Expression profiling by array.
Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
GEO Series GSE43878. Homo sapiens. 40 samples. Type: Expression profiling by array.
Phenotypic and genomic analysis of multiple myeloma minimal residual disease clonal plasma cells: a new model to understand chemoresistance [HuGene-1_0 Expression]
GEO Series GSE70398. Homo sapiens. 14 samples. Type: Expression profiling by array.
Gene expression profiles of multiple myeloma plasma cell fractions from bone marrow II
GEO Series GSE99635. Homo sapiens. 35 samples. Type: Expression profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.